Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Lipid regulating medicines consumption assessment in republic of serbia during the period 2003-2005 year

  • At: 2006 FIP Congress in Salvadore (Brazil)
  • Type: Poster
  • By: RADONJIC (Medicines and Medical devices Agency, Belgrade, Yugoslavia)
  • Co-author(s): Radonjic, Vesela (Medicines and Medical devices Agency, BELGRADE, Serbia and Montenegro)
    Solarovic, Tomislav (Medicines and Medical devices Agency, BELGRADE, Serbia and Montenegro)
  • Abstract:

    Lowering the concentration of low density lipoprotein (LDL) cholesterol and raising high density lipoprotein (HDL) cholesterol reduces the progression of coronary atherosclerosis and may induce regresion , it stands to reason on significance of lipid regulating medicines.

    The aim of our study was the following consumption of lipid regulating..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses